EPINEPHRINE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC for the procurement of two units of EPINEPHRINE INJECTION, identified by NSN 6505011533042 and NDC 76329-9061-00, at a total contract price of $19.26. The award was issued on July 20, 2026, through the DIBBS system, reflecting a streamlined, low-value acquisition processed under simplified procedures. Delivery is scheduled for August 4, 2026, to the specified location at Building 5505A, Wickham Avenue, Fort Campbell, Kentucky, with all terms defined as FOB Destination, placing full responsibility for transportation, risk, and delivery compliance on the contractor. The item must be shipped via traceable means only, with parcel post explicitly prohibited, and each unit must bear the Transportation Control Number W34GMT61980032 along with the contractor’s CAGE code 3FFJ6. Inspection and acceptance occur at the destination point, with zero tolerance for quantity variance, requiring exact compliance with the ordered quantity of two units. The contract references no formal clauses from FAR or DFARS, no attachments, no detailed technical specifications, and no certified representations from the offeror beyond the CAGE code 1UNB0. There are no stated quality standards such as USP or MIL-SPEC, no barcoding requirements, and no mention of packaging or preservation standards beyond the prohibition of parcel post. Financial identifiers include PR 7017564601, DIC code A0A, IPD 12, and fund code Z9, though no payment office or invoicing protocol is specified. The absence of evaluation factors, contract type designation, or administrative contact details underscores the simplified nature of this transaction, consistent with a minor acquisition handled under automated procurement systems. No option periods, extensions, or additional line items are included, and the delivery order is treated as a standalone fulfillment under the overarching IDIQ contract.